Adage Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $128M | Buy |
916,513
+75,348
| +9% | +$10.6M | 0.2% | 97 |
|
|
2025
Q4 | $103M | Sell |
841,165
-514,083
| -38% | -$62.5M | 0.16% | 123 |
|
|
2025
Q3 | $150M | Sell |
1,355,248
-97,984
| -7% | -$11.1M | 0.24% | 74 |
|
|
2025
Q2 | $161M | Buy |
1,453,232
+133,080
| +10% | +$14.2M | 0.27% | 61 |
|
|
2025
Q1 | $148M | Sell |
1,320,152
-393,978
| -23% | -$40.7M | 0.27% | 68 |
|
|
2024
Q4 | $158M | Buy |
+1,714,130
| New | +$154M | 0.28% | 60 |
|
|
2024
Q2 | – | Sell |
-101,387
| Closed | -$7.43M | – | 896 |
|
|
2024
Q1 | $7.43M | Buy |
+101,387
| New | +$7.8M | 0.01% | 650 |
|
|
2023
Q3 | – | Sell |
-1,246,588
| Closed | -$96.1M | – | 898 |
|
|
2023
Q2 | $96.1M | Sell |
1,246,588
-385,596
| -24% | -$30.8M | 0.21% | 118 |
|
|
2023
Q1 | $135M | Buy |
1,632,184
+75,500
| +5% | +$6.25M | 0.3% | 77 |
|
|
2022
Q4 | $134M | Buy |
1,556,684
+585,707
| +60% | +$46.4M | 0.32% | 63 |
|
|
2022
Q3 | $59.9M | Sell |
970,977
-119,300
| -11% | -$7.52M | 0.15% | 160 |
|
|
2022
Q2 | $67.4M | Buy |
1,090,277
+898,300
| +468% | +$55.6M | 0.15% | 137 |
|
|
2022
Q1 | $11.4M | Sell |
191,977
-818,800
| -81% | -$52.3M | 0.02% | 659 |
|
|
2021
Q4 | $73.4M | Buy |
1,010,777
+961,300
| +1,943% | +$66.2M | 0.13% | 162 |
|
|
2021
Q3 | $3.46M | Sell |
49,477
-569,300
| -92% | -$40M | 0.01% | 866 |
|
|
2021
Q2 | $42.6M | Buy |
618,777
+556,200
| +889% | +$37.1M | 0.08% | 250 |
|
|
2021
Q1 | $4.04M | Sell |
62,577
-1,400
| -2% | -$90.3K | 0.01% | 820 |
|
|
2020
Q4 | $3.73M | Sell |
63,977
-231,000
| -78% | -$13.9M | 0.01% | 714 |
|
|
2020
Q3 | $18.6M | Buy |
+294,977
| New | +$20.5M | 0.05% | 394 |
|
|
2020
Q2 | – | Sell |
-1,112,325
| Closed | -$83.2M | – | 765 |
|
|
2020
Q1 | $83.2M | Sell |
1,112,325
-151,100
| -12% | -$10.4M | 0.25% | 104 |
|
|
2019
Q4 | $82.1M | Sell |
1,263,425
-78,000
| -6% | -$5.08M | 0.2% | 132 |
|
|
2019
Q3 | $85M | Sell |
1,341,425
-14,200
| -1% | -$928K | 0.21% | 122 |
|
|
2019
Q2 | $91.6M | Buy |
1,355,625
+81,100
| +6% | +$5.34M | 0.23% | 117 |
|
|
2019
Q1 | $82.9M | Sell |
1,274,525
-302,700
| -19% | -$20.1M | 0.21% | 124 |
|
|
2018
Q4 | $98.7M | Buy |
1,577,225
+51,731
| +3% | +$3.62M | 0.27% | 104 |
|
|
2018
Q3 | $118M | Sell |
1,525,494
-92,600
| -6% | -$6.99M | 0.26% | 101 |
|
|
2018
Q2 | $115M | Sell |
1,618,094
-137,896
| -8% | -$9.74M | 0.26% | 95 |
|
|
2018
Q1 | $132M | Buy |
1,755,990
+292,330
| +20% | +$23.2M | 0.31% | 84 |
|
|
2017
Q4 | $105M | Sell |
1,463,660
-165,600
| -10% | -$12.6M | 0.24% | 114 |
|
|
2017
Q3 | $132M | Sell |
1,629,260
-145,232
| -8% | -$11.1M | 0.32% | 77 |
|
|
2017
Q2 | $126M | Sell |
1,774,492
-175,600
| -9% | -$11.7M | 0.31% | 78 |
|
|
2017
Q1 | $132M | Buy |
1,950,092
+26,000
| +1% | +$1.83M | 0.33% | 75 |
|
|
2016
Q4 | $138M | Sell |
1,924,092
-224,100
| -10% | -$16.7M | 0.38% | 69 |
|
|
2016
Q3 | $170M | Buy |
2,148,192
+489,155
| +29% | +$39.7M | 0.47% | 49 |
|
|
2016
Q2 | $138M | Sell |
1,659,037
-80,500
| -5% | -$7.14M | 0.38% | 77 |
|
|
2016
Q1 | $160M | Buy |
1,739,537
+258,807
| +17% | +$23.3M | 0.43% | 64 |
|
|
2015
Q4 | $150M | Sell |
1,480,730
-198,600
| -12% | -$20.7M | 0.39% | 72 |
|
|
2015
Q3 | $165M | Sell |
1,679,330
-482,400
| -22% | -$53.6M | 0.46% | 53 |
|
|
2015
Q2 | $253M | Buy |
2,161,730
+146,000
| +7% | +$16M | 0.63% | 29 |
|
|
2015
Q1 | $198M | Sell |
2,015,730
-384,000
| -16% | -$39M | 0.48% | 43 |
|
|
2014
Q4 | $226M | Sell |
2,399,730
-612,200
| -20% | -$63.3M | 0.55% | 37 |
|
|
2014
Q3 | $321M | Sell |
3,011,930
-217,750
| -7% | -$21.3M | 0.79% | 15 |
|
|
2014
Q2 | $268M | Sell |
3,229,680
-1,579,814
| -33% | -$123M | 0.69% | 26 |
|
|
2014
Q1 | $341M | Buy |
4,809,494
+650,500
| +16% | +$51M | 0.93% | 13 |
|
|
2013
Q4 | $312M | Buy |
4,158,994
+282,000
| +7% | +$19.6M | 0.83% | 15 |
|
|
2013
Q3 | $244M | Sell |
3,876,994
-957,000
| -20% | -$57.2M | 0.7% | 22 |
|
|
2013
Q2 | $248M | Buy |
+4,833,994
| New | +$252M | 0.76% | 18 |
|
Other funds holding GILD
VCM
VPM
Adage Capital Partners's GILD Position: Q1 2026 in Review
Adage Capital Partners increased its Gilead Sciences (GILD) stake by 9% in Q1 2026, buying an estimated $10.6M and bringing the position to 916,513 shares worth $128M. The position accounts for 0.2% of the portfolio, ranked #97.
Adage Capital Partners first reported a position in GILD in Q2 2013 and has held it in 47 quarters since. The position peaked at $341M in Q1 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Adage Capital Partners held 916,513 shares of Gilead Sciences worth $128M as of Q1 2026.
- Adage Capital Partners bought 75,348 Gilead Sciences shares in Q1 2026, an estimated $10.6M.
- Gilead Sciences made up 0.2% of Adage Capital Partners's portfolio in Q1 2026, its #97 holding.
- Adage Capital Partners first reported a position in Gilead Sciences in Q2 2013 and has held it in 47 quarters since.
- Adage Capital Partners's Gilead Sciences position peaked at $341M in Q1 2014.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.